297 related articles for article (PubMed ID: 2196786)
1. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
[TBL] [Abstract][Full Text] [Related]
2. Development of early squamous cell carcinoma of the esophagus after endoscopic injection sclerotherapy for esophageal varices.
Tanoue K; Hashizume M; Ohta M; Ueno K; Kitano S; Sugimachi K
Hepatogastroenterology; 1995; 42(6):792-6. PubMed ID: 8847025
[TBL] [Abstract][Full Text] [Related]
3. [Esophageal carcinoma after the endoscopic sclerotherapy of varices].
Macías Rodríguez MA; Soria de la Cruz MJ; Iglesias Arrabal M; Martín Herrera L
Rev Esp Enferm Dig; 1992 Jul; 82(1):43-6. PubMed ID: 1520550
[TBL] [Abstract][Full Text] [Related]
4. Development of esophageal cancer after endoscopic injection sclerotherapy for esophageal varices: three case reports.
Ohta M; Kuwano H; Hashizume M; Sonoda T; Tomikawa M; Higashi H; Ohno S; Watanabe M; Sugimachi K
Endoscopy; 1995 Aug; 27(6):455-8. PubMed ID: 8549446
[TBL] [Abstract][Full Text] [Related]
5. [A case of carcinoma of the esophagus developing two years after endoscopic injection sclerotherapy of esophageal varices].
Umekita N; Idezuki Y; Kawasaki S; Sanjo K; Beppu T
Nihon Shokakibyo Gakkai Zasshi; 1985 Jul; 82(7):1761-4. PubMed ID: 4079093
[No Abstract] [Full Text] [Related]
6. Development of squamous cell carcinoma of the esophagus after endoscopic variceal sclerotherapy.
Bochna GS; Harty RF; Harned RK; Markin RS
Am J Gastroenterol; 1988 May; 83(5):564-8. PubMed ID: 3364414
[TBL] [Abstract][Full Text] [Related]
7. [Early esophageal cancer discovered 6 months after endoscopic injection sclerotherapy of esophageal varices].
Nakamura R; Watanabe M; Sugimura Y; Kondoh M; Saitoh K; Sasou S
Gan No Rinsho; 1988 Aug; 34(9):1190-4. PubMed ID: 3172524
[TBL] [Abstract][Full Text] [Related]
8. Adenosquamous carcinoma of the esophagus after endoscopic variceal sclerotherapy: a case report and review of the literature.
Sakata K; Ishida M; Hiraishi H; Sasai T; Watanabe N; Suzuki Y; Masuyama H; Terano A
Gastrointest Endosc; 1998 Mar; 47(3):294-9. PubMed ID: 9540886
[No Abstract] [Full Text] [Related]
9. Endoscopic injection sclerotherapy for esophagogastric variceal bleeding in children with biliary atresia.
Horigome H; Nomura T; Saso K; Hashimoto T; Suzuki T; Joh T; Ohara H; Akita S; Sobue S; Mizuno Y; Kato Y; Ohmi H; Itoh M
Hepatogastroenterology; 1999; 46(30):3060-2. PubMed ID: 10626160
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
[TBL] [Abstract][Full Text] [Related]
11. Sclerosant extravasation following endoscopic injection sclerotherapy for bleeding gastric varices.
Akimoto K; Inamori M; Akiyama T; Endo H; Fujita K; Yoneda M; Takahashi H; Goto A; Abe Y; Kirikoshi H; Kobayashi N; Kubota K; Saito S; Ueno N; Nakajima A
Endoscopy; 2007 Feb; 39 Suppl 1():E242. PubMed ID: 17957650
[No Abstract] [Full Text] [Related]
12. Pathological findings in the esophagus after endoscopic sclerotherapy for variceal bleeding.
Pushpanathan C; Idikio H
Am J Gastroenterol; 1986 Jan; 81(1):9-13. PubMed ID: 3484607
[No Abstract] [Full Text] [Related]
13. Carcinoma of the esophagus and long-term sclerotherapy.
McCormick PA; Sawyer A; McIntyre N; Burroughs AK
Endoscopy; 1989 May; 21(3):152. PubMed ID: 2787240
[TBL] [Abstract][Full Text] [Related]
14. [Carcinoma of the gastroesophageal junction following variceal sclerosis: more than a coincidence?].
Larrubia JR; Mendoza JL; Cigüenza R; Lana R; González JF; Espinós D
Gastroenterol Hepatol; 1998 Jan; 21(1):6-9. PubMed ID: 9503745
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
16. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.
Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H
Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk factors for bleeding after first course of endoscopic injection sclerotherapy: a univariate and multivariate analysis.
Kokawa H; Shijo H; Kubara K; Nakaoka K; Toriya H; Shirai Z; Okazaki M
Am J Gastroenterol; 1993 Aug; 88(8):1206-11. PubMed ID: 8393274
[TBL] [Abstract][Full Text] [Related]
18. Complications of endoscopic sclerotherapy of esophageal varices.
Baillie J; Yudelman P
Endoscopy; 1992 May; 24(4):284-91. PubMed ID: 1612042
[No Abstract] [Full Text] [Related]
19. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate.
Kitano S; Koyanagi N; Iso Y; Higashi H; Sugimachi K
Hepatology; 1987; 7(5):810-5. PubMed ID: 3498673
[TBL] [Abstract][Full Text] [Related]
20. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal.
Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K
Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
